88,412 Alpha Teknova, Inc. $TKNO Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC reduced its stake in shares of Alpha Teknova, Inc. (NASDAQ:TKNO – Free Report) by 71.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,948 shares of the company’s stock after selling 88,412 shares during the quarter. Squarepoint Ops LLC owned about 0.07% of Alpha Teknova worth $204,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Susquehanna International Group LLP bought a new stake in shares of Alpha Teknova during the 2nd quarter worth about $115,000. Bank of America Corp DE acquired a new position in shares of Alpha Teknova during the second quarter valued at approximately $1,453,000. Ieq Capital LLC acquired a new position in shares of Alpha Teknova during the 2nd quarter valued at $62,000. BlackRock Inc. acquired a new stake in shares of Alpha Teknova in the second quarter valued at $4,997,000. Finally, Deutsche Bank AG acquired a new stake in shares of Alpha Teknova in the second quarter valued at $62,000. Institutional investors own 13.81% of the company’s stock.

Alpha Teknova, Inc. has a 12 month low of $1.91 and a 12 month high of $9.41.

Alpha Teknova last released its quarterly earnings data on Wednesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. The company had revenue of $12.19 million during the quarter, compared to analysts’ expectations of $10.95 million. Alpha Teknova had a negative return on equity of 24.94% and a negative net margin of 38.37%.The firm had revenue of $12.19 million during the quarter, compared to analysts’ expectations of $10.95 million. As a group, sell-side analysts forecast that Alpha Teknova, Inc. will post -0.28 EPS for the current fiscal year.

A number of research analysts recently issued reports on the company. Wall Street Zen raised Alpha Teknova from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Zacks Research raised Alpha Teknova to a “hold” rating in a report on Thursday, August 6th. Weiss Ratings downgraded Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. Roth Capital started coverage on Alpha Teknova in a research note on Wednesday, August 5th. They set a “buy” rating and a $7.00 price objective for the company. Finally, BTIG Research raised Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price objective for the company in a research note on Tuesday, August 11th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $8.00.

Alpha Teknova, Inc (NASDAQ: TKNO) develops and manufactures critical reagents and solutions used in life sciences research, biopharmaceutical development, and laboratory testing. The company supplies ready-to-use and custom-formulated biological buffers, media, process liquids, and...